Bessemer Group Inc Ptc Therapeutics, Inc. Transaction History
Bessemer Group Inc
- $55.8 Billion
- Q1 2025
A detailed history of Bessemer Group Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 80 shares of PTCT stock, worth $3,980. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80
Previous 85
5.88%
Holding current value
$3,980
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PTCT
# of Institutions
264Shares Held
72.6MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$457 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$387 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$368 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$317 Million4.07% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.29MShares$164 Million0.24% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.56B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...